Finally, we assessed whether our nanostructures, through their targeting of p53 proteins, could revert the acquired chemoresistance typical of certain mutp53 cancer cells and therefore represent a personalized treatment for cancer patients with alterations in the TP53 gene. Here, TP53 is linked to cancer.